Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yuhan Lyu"'
Publikováno v:
JACS Au, Vol 4, Iss 7, Pp 2484-2491 (2024)
Externí odkaz:
https://doaj.org/article/1179e2c6dcb043139ddb8c4dc7c7d1e1
Publikováno v:
Diversity, Vol 15, Iss 1, p 41 (2022)
The population genetic structure of 211 samples of Loliolus (Nipponololigo) beka, which were selected from across seven geographic localities—in the Bohai Sea, the Yellow Sea and the East China Sea—were analyzed using mitochondrial COI and 16S rR
Externí odkaz:
https://doaj.org/article/dc591f72efa748d2a9083026cc59d724
Autor:
Qiaosen Chen, Ding Zeng, Yangyang She, Yuhan Lyu, Xiao Gong, Matthew J. Feinstein, Yi Yang, Hongbo Jiang
Publikováno v:
EClinicalMedicine, Vol 16, Iss , Pp 121-128 (2019)
Background: A substantial proportion of people living with HIV (PLHIV) present for care with advanced HIV disease (AHD), which may result in difficulty reaching the “90–90–90” target to end AIDS in 2030. We assessed the risk of AHD for differ
Externí odkaz:
https://doaj.org/article/b993c02317a74a67a9c63828fdd23517
Publikováno v:
J Am Chem Soc
We report a new reversible lysine conjugation that features a novel diazaborine product and much slowed dissociation kinetics in comparison to the previously known iminoboronate chemistry. Incorporating the diazaborine-forming warhead RMR1 to a pepti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc8ae71acb3011f2b287b94a3318d61a
https://europepmc.org/articles/PMC8928449/
https://europepmc.org/articles/PMC8928449/
Autor:
Min, Li, Xudong, Dong, Qiubo, Lyu, Pingping, Li, Yuhan, Lyu, Guifang, Zhang, Tianzi, Gai, Qing, Feng, Chunxue, Yang, Yaxin, Liang
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica; Feb2023, Vol. 102 Issue 2, p200-208, 9p
Autor:
Yuhan Lyu, Matthew J. Feinstein, Yangyang She, Qiaosen Chen, Yi Yang, Ding Zeng, Xiao Gong, Hongbo Jiang
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 16, Iss, Pp 121-128 (2019)
EClinicalMedicine, Vol 16, Iss, Pp 121-128 (2019)
Background A substantial proportion of people living with HIV (PLHIV) present for care with advanced HIV disease (AHD), which may result in difficulty reaching the “90–90–90” target to end AIDS in 2030. We assessed the risk of AHD for differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::306bcb15e936ed4f90432a4ebe2d877d
https://doi.org/10.1016/j.eclinm.2019.10.003
https://doi.org/10.1016/j.eclinm.2019.10.003